Fig. 1From: Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1Comparison between chemotherapy and haplo-SCT with landmark. a Cumulative incidence of relapse (CIR). b Non-relapse mortality (NRM). c Leukemia-free survival (LFS). d Overall survival (OS)Back to article page